These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16971774)

  • 1. [Pharmacogenomics of cardiovascular pharmacology].
    Tanaka T; Oka T; Iwao H
    Nihon Yakurigaku Zasshi; 2006 Sep; 128(3):130-2. PubMed ID: 16971774
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical Implementation of Cardiovascular Pharmacogenomics.
    Pereira NL; Stewart AK
    Mayo Clin Proc; 2015 Jun; 90(6):701-4. PubMed ID: 26046404
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacogenomics and cardiology: improving treatment with existing drugs.
    Sorrentino MJ; O'Donnell PH
    Pharmacogenomics; 2015; 16(11):1223-6. PubMed ID: 26369612
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy.
    Mango R; Vecchione L; Raso B; Borgiani P; Brunetti E; Mehta JL; Lauro R; Romeo F; Novelli G
    Expert Opin Pharmacother; 2005 Dec; 6(15):2565-76. PubMed ID: 16316297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics: the genetics of variable drug responses.
    Roden DM; Wilke RA; Kroemer HK; Stein CM
    Circulation; 2011 Apr; 123(15):1661-70. PubMed ID: 21502584
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacogenetics--new perspectives in the treatment of cardiovascular diseases].
    Dzida G
    Kardiol Pol; 2004 Mar; 60(3):304-8. PubMed ID: 15156230
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacogenetics, pharmacogenomics, and cardiovascular therapeutics: the way forward.
    Terra SG; Johnson JA
    Am J Cardiovasc Drugs; 2002; 2(5):287-96. PubMed ID: 14727958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular pharmacogenomics and individualized drug therapy.
    Pereira NL; Weinshilboum RM
    Nat Rev Cardiol; 2009 Oct; 6(10):632-8. PubMed ID: 19707183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics to Revive Drug Development in Cardiovascular Disease.
    Dubé MP; de Denus S; Tardif JC
    Cardiovasc Drugs Ther; 2016 Feb; 30(1):59-64. PubMed ID: 26768480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent developments and future directions for the use of pharmacogenomics in cardiovascular disease treatments.
    Berinstein E; Levy A
    Expert Opin Drug Metab Toxicol; 2017 Sep; 13(9):973-983. PubMed ID: 28792790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of contemporary genetics in cardiovascular diagnosis.
    George AL
    Circulation; 2014 Nov; 130(22):1971-80. PubMed ID: 25421045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular pharmacogenomics: the future of cardiovascular therapeutics?
    Roden DM
    Can J Cardiol; 2013 Jan; 29(1):58-66. PubMed ID: 23200096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular pharmacogenetics.
    Myburgh R; Hochfeld WE; Dodgen TM; Ker J; Pepper MS
    Pharmacol Ther; 2012 Mar; 133(3):280-90. PubMed ID: 22123178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review on pharmacogenetics in cardiovascular disease: is it ready for clinical application?
    Verschuren JJ; Trompet S; Wessels JA; Guchelaar HJ; de Maat MP; Simoons ML; Jukema JW
    Eur Heart J; 2012 Jan; 33(2):165-75. PubMed ID: 21804109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomics and the prospects of existing and emerging therapeutics for cardiovascular diseases.
    Zaiou M; Benachour H; Marteau JB; Visvikis-Siest S; Siest G
    Curr Pharm Des; 2009; 15(27):3193-206. PubMed ID: 19754391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics in cardiology--genetics and drug response: 10 years of progress.
    Cavallari LH; Weitzel K
    Future Cardiol; 2015 May; 11(3):281-6. PubMed ID: 26021633
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacogenomics and management of cardiovascular disease.
    Howe LA
    Nursing; 2011; 41 Suppl():1-7. PubMed ID: 21343749
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular pharmacogenomics.
    Roden DM
    Circulation; 2003 Dec; 108(25):3071-4. PubMed ID: 14691022
    [No Abstract]   [Full Text] [Related]  

  • 19. New collaborations make pharmacogenomics a SNP.
    Dawson E
    Mol Med Today; 1999 Jul; 5(7):280. PubMed ID: 10377514
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacogenetics of cardiovascular drugs.
    Saleh A; Al-Abcha A; Pereira N
    Curr Opin Cardiol; 2023 May; 38(3):207-214. PubMed ID: 37016993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.